Virus strains and clinical samples
In this study, the nucleic acid of all the virus strains was isolated from clinical samples that had tested positive by PCR assays and preserved at -20 °C until further use. The viral sequences were uploaded to GenBank. A total of 165 clinical samples, comprising feces and small intestines from bovines with diarrhea symptoms, were collected in China between 2021 and 2022. Samples were stored in the laboratory before analysis.
Nucleic acid extraction and reverse transcription
Positive samples were treated with PBS(phosphate buffer saline), and the supernatant was collected. RNA was extracted following the manufacturer's instructions from the samples using an automatic nucleic acid extraction instrument (Xian Tianlong Science & Technology Co.Ltd). (5×)PrimeScriptRT Master Mix Kit (Takara, Dalian, China) was used to reverse-transcribe the extracted RNA into cDNA following the manufacturer’s instructions. All DNA and cDNA products were stored at -20 °C until use.
Design of specific primers and probe
The conservation of genes was determined for designing specific probes and primers using Primer Premier 5 software. Using the Basic Local Alignment Search Tool, we examined potential cross-reactivity and target specificity. Primers and probes were synthesized by Takara Biomedical Technology (Dalian, China). The details data are presented in Table 1.
Table 1. Primers and probes designed for the multiplex fqPCR
Virus
|
Primer/probe
|
Sequence(5’-3’)
|
Size(bp)
|
Target gene
|
Reference
|
|
|
|
|
|
|
|
F
|
TCAACTCTTTCTGGAAAATCTATT
|
221bp
256bp
215bp
|
5’UTR
5’UTR
5’UTR
|
This Study
This Study
This Study
|
BRV
|
R
|
TCTGGAGACTTCGACAACATGTA
|
|
Probe
|
FAM-AGTGAACAATACATTTCACCAGATGC-BHQ1
|
|
|
|
|
F
|
GAGTTCGTTGGATGGCTGAA
|
BVDV
|
R
|
CGCACAAAGCGTCGAACCACT
|
|
Probe
|
Texas Red- TGAGTACAGGGTAGTCGT-MGB
|
|
|
|
|
F
|
GGCCGTGAATGCTGCTAATC
|
BEV
|
R
|
CGCGTTACGACGTAGCAACA
|
|
Probe
|
CY5-AACCTCCGAGCGTGTGCGCA(G)C-BHQ3
|
Preparation of standard plasmids
Target fragments of BRV, BVDV-1, and BEV were amplified by PCR, using the same primers as those used for multiplex fqPCR.The total reaction volume was 25 µL, including 12.5 µL of Takara LA Taq DNA Polymerase, 100 nmol forward and reverse primers, and 1 µL of template DNA. Sterile water was added to make up the final volume to 25 µL. The cycling reaction conditions were as follows: 94 °C for 5 min, 40 cycles of 94 °C for 30 s, 60 °C for 30 s, 72 °C for 30 s, and 72°C for 10 min. Sterile water was used as a negative control. The PCR was conducted on a hema96TC instrument. The PCR product was separated by agarose gel electrophoresis, and the TaKaRa MiniBEST Agarose Gel DNA Extraction Kit Ver.4.0 was used for recovery of nucleic acids from the gel; pGEM-T Easy was used and the nucleic acids were cloned into JM109 receptor cells. Then, the bacterial cultures were shaken and grown for 10–14h at 37 ℃. The positive plasmids were extracted and concentrations were measured. The recombination plasmids were confirmed by Takara Biomedical Technology (Dalian, China). The copy number of extracted plasmid was calculated as follows:
The plasmid was diluted 10-fold to calculate the copy number, and the plasmid concentration was diluted from 1×107 copies/µL to 1×101 copies/µL, which was used for a single fqPCR assay of each virus to generate three standard curves. The standard equation was calculated according to the E-value (amplification efficiency) and R2 value (correlation coefficient).
Optimization of the single and multiplex TaqMan fqPCR assays
The single system fqPCR comprised 12.5 µL of 2×TaqMan fqPCR Master Mix,100 nmol forward and reverse primers,100 nmol probe, and 1 µL template DNA; sterile water was added to a total volume of 25 µL. The end of the reaction system was optimized by the matrix method. Multiplex fqPCR was conducted after several optimizations of the reaction system composition to determine the optimal multiple reaction system. The thermal cycling procedure was as follows: 95 °C for 5 min, 40 cycles of 95 °C for 30 s, and 58 °C for 30 s. Signals were automatically collected at the end of each cycle. Amplification was performed using LightCycler® 96 (Applied Biosystems). The fluorescence channels of the fqPCR instrument were set as follows: channel 1, FAM; channel 2, Texas Red, and channel 3, Cy5. Fluorescence signals were also collected with the fqPCR instrument.
Sensitivity test for the multiplex fqPCR assay
The correct plasmids which were confirmed by sequencing were diluted from 106 to 101 copies/µL, as the template, and the detection limit of the multiplex fqPCR was examined. Three replicates were used for each concentration.
Specificity test of the multiplex fqPCR assay
To confirm the specificity of multiplex fqPCR and avoid false positive results due to other viruses, using multiplex fqPCR to detect BPV, BCOV, BNoV, BKoV, and BoAstV which were stored in the laboratory. Sterile water was used as the negative control.
Repeatability test of the multiplex fqPCR assay
To ensure the stability of the experiment, repeated test was conducted by different experimenters on different instruments for various periods, and intra-assay and inter-assay analyses were conducted for experimental data.
Examination of clinical samples using multiplex fqPCR
From 2021 to 2022, the feces and intestinum tenue from 165 bovines in China were collected. The clinical samples were collected and physiological saline was immediately added for storage at -80 °C. Multiplex fqPCR assay was conducted for all samples to determine the virus positivity of the samples. To ensure the authenticity and reliability of the procedure, all positive samples were sequenced by Takara Biomedical Technology (Dalian, China). The infection rate of each virus was analyzed after obtaining the assay results of all clinical samples.